<p>FemTech represents a trillion-dollar opportunity. So why do all-female teams receive just 2% of early-stage venture capital?</p><p>Beata Wandachowicz-Krason has spent years researching what is holding FemTech back — the funding gaps, the cultural taboos, and the structural misalignment between how healthcare systems are built and what women’s health actually requires. </p><p>In this episode, she breaks down why the relatability gap between female founders and male investors is one of the biggest blockers in the sector, and what founders can do about it right now.</p><p>You’ll hear why pitching FemTech as a social cause is the wrong move, how to pivot from risk-based investor questions back to growth, and why male allyship is not optional if the sector is going to scale.</p><p><strong>What we cover:</strong></p><ul><li>The funding paradox: 85% female-led ventures, 2% of VC funding</li><li>Why 90% male VC decision-making creates a structural relatability problem</li><li>Cultural taboos around menopause, miscarriage, and chronic pain — and how they suppress both patient voices and founder credibility</li><li>How healthcare systems optimized for acute care create a prevention gap that FemTech is trying to fill</li><li>Why AI tools are censoring the very medical terms that took decades to legitimize</li><li>How to build a data-driven, economically aggressive pitch that moves FemTech out of the wellness niche</li><li>The pivot technique: answering risk-based questions without losing the growth narrative</li><li>Why male allyship — done right — accelerates the sector rather than co-opting it</li><li>Data privacy in women’s health: why the taboo is a bigger barrier than the technology</li><li>Practical tools for combating gender bias in the funding process</li></ul><p><strong>About Beata Wandachowicz-Krason</strong><br>Beata is an executive at Organon and a researcher focused on the systemic barriers holding FemTech back. She works at the intersection of women’s health, venture capital, and ecosystem building.</p><p><strong>Resources mentioned in the episode:</strong></p><ul><li>Funding Coach: <a href="http://fundingcoach.ai">⁠fundingcoach.ai⁠</a></li><li>Pieter van Keep and early menopause research: <a href="https://pubmed.ncbi.nlm.nih.gov/9089556/">⁠https://pubmed.ncbi.nlm.nih.gov/9089556/⁠</a></li></ul><p>Related episodes: </p><ul><li>Sabrina Nowicki </li><li>Carmen van Vilsteren </li><li>Femke Delissen</li><li>Ida Tin</li><li>Sara Okhuijsen</li></ul><p>Connect with Beata: <a href="https://www.linkedin.com/in/beata-wandachowicz-krason/">⁠https://www.linkedin.com/in/beata-wandachowicz-krason/⁠</a></p><p>Find the show notes: <a href="https://womendisruptingtech.blog/2026/06/04/episode-155/">https://womendisruptingtech.blog/2026/06/04/episode-155/</a></p><p>Follow Women Disrupting Tech on Spotify and Apple Podcasts for weekly conversations with the women reshaping technology and healthcare.</p>

Women Disrupting Tech

Dirkjan Hupkes

How Female Founders Can Pitch FemTech to Male Investors with Beata Wandachowicz-Krason | Ep. 155

JUN 4, 202685 MIN
Women Disrupting Tech

How Female Founders Can Pitch FemTech to Male Investors with Beata Wandachowicz-Krason | Ep. 155

JUN 4, 202685 MIN

Description

<p>FemTech represents a trillion-dollar opportunity. So why do all-female teams receive just 2% of early-stage venture capital?</p><p>Beata Wandachowicz-Krason has spent years researching what is holding FemTech back — the funding gaps, the cultural taboos, and the structural misalignment between how healthcare systems are built and what women’s health actually requires. </p><p>In this episode, she breaks down why the relatability gap between female founders and male investors is one of the biggest blockers in the sector, and what founders can do about it right now.</p><p>You’ll hear why pitching FemTech as a social cause is the wrong move, how to pivot from risk-based investor questions back to growth, and why male allyship is not optional if the sector is going to scale.</p><p><strong>What we cover:</strong></p><ul><li>The funding paradox: 85% female-led ventures, 2% of VC funding</li><li>Why 90% male VC decision-making creates a structural relatability problem</li><li>Cultural taboos around menopause, miscarriage, and chronic pain — and how they suppress both patient voices and founder credibility</li><li>How healthcare systems optimized for acute care create a prevention gap that FemTech is trying to fill</li><li>Why AI tools are censoring the very medical terms that took decades to legitimize</li><li>How to build a data-driven, economically aggressive pitch that moves FemTech out of the wellness niche</li><li>The pivot technique: answering risk-based questions without losing the growth narrative</li><li>Why male allyship — done right — accelerates the sector rather than co-opting it</li><li>Data privacy in women’s health: why the taboo is a bigger barrier than the technology</li><li>Practical tools for combating gender bias in the funding process</li></ul><p><strong>About Beata Wandachowicz-Krason</strong><br>Beata is an executive at Organon and a researcher focused on the systemic barriers holding FemTech back. She works at the intersection of women’s health, venture capital, and ecosystem building.</p><p><strong>Resources mentioned in the episode:</strong></p><ul><li>Funding Coach: <a href="http://fundingcoach.ai">⁠fundingcoach.ai⁠</a></li><li>Pieter van Keep and early menopause research: <a href="https://pubmed.ncbi.nlm.nih.gov/9089556/">⁠https://pubmed.ncbi.nlm.nih.gov/9089556/⁠</a></li></ul><p>Related episodes: </p><ul><li>Sabrina Nowicki </li><li>Carmen van Vilsteren </li><li>Femke Delissen</li><li>Ida Tin</li><li>Sara Okhuijsen</li></ul><p>Connect with Beata: <a href="https://www.linkedin.com/in/beata-wandachowicz-krason/">⁠https://www.linkedin.com/in/beata-wandachowicz-krason/⁠</a></p><p>Find the show notes: <a href="https://womendisruptingtech.blog/2026/06/04/episode-155/">https://womendisruptingtech.blog/2026/06/04/episode-155/</a></p><p>Follow Women Disrupting Tech on Spotify and Apple Podcasts for weekly conversations with the women reshaping technology and healthcare.</p>